Industry-Supported Symposium
Karen Costenbader, MD, MPH
Brigham and Women's Hospital/ Harvard Medical School
BOSTON, MA, United States
Disclosure information not submitted.
Rosalind Ramsey-Goldman, MD, DrPH
Northwestern University
Chicago, Illinois, United States
Disclosure information not submitted.
Jinoos Yazdany, MD, MPH
UCSF
San Francisco, California, United States
Disclosure information not submitted.
Please note: This session is not eligible for CME Credits through ACR.
This session will not be recorded for on-demand.
This session explores the evolving landscape in systemic lupus erythematosus (SLE), with an emphasis on the importance of incorporating relevant outcomes in trial design and clinical practice. We will discuss how a detailed understanding of the full spectrum of a patient’s disease experience can enhance care and look to the future with the potential application of digital advances e.g. artificial intelligence, in SLE management. Developed and offered by UCB Biopharma SRL. Not an official program of the ACR.
